ERBB2 and breast cancer: Triple negative breast cancer (TNBC) accounts for approximately 15% of all breast cancers and is defined by lack of expression of estrogen and progesterone receptors, and lack of overexpression of human epidermal growth factor receptor 2 (HER2).